Core Viewpoint - Chengdu Kanghong Pharmaceutical Group Co., Ltd. has announced its 2024 annual profit distribution plan, which includes a cash dividend distribution to shareholders based on the company's total share capital as of April 25, 2025 [1][2]. Summary by Sections Shareholder Meeting Approval - The profit distribution plan for 2024 was approved at the shareholder meeting held on May 21, 2025, with a total cash dividend of 551,921,402.40 yuan based on the total share capital of 919,869,004 shares [1]. Distribution Plan Details - The final cash dividend distribution will amount to 552,673,862.40 yuan, calculated based on the adjusted total share capital of 921,123,104 shares, which includes an increase of 1,254,100 shares due to the exercise of stock options [2]. - The distribution will be 5.4 yuan for every 10 shares held, with different tax treatments for various categories of shareholders [2]. Key Dates - The record date for the distribution is set for June 5, 2025, and the ex-dividend date will follow [2][3]. Distribution Method - Cash dividends will be directly credited to the shareholders' accounts through their custodial securities companies starting June 6, 2025 [3]. Stock Option Adjustment - The company will adjust the exercise price of stock options under the 2021 stock option incentive plan following the distribution, in accordance with relevant regulations [4]. Consultation Information - For inquiries regarding the distribution, shareholders can contact the company's board office at the provided address and phone number [4].
康弘药业: 二〇二四年度权益分派实施公告